Comments on “The relation between Helicobacter pylori infection and cardiac syndrome X: A preliminary study", Assadi M, et al.

Abstract

[1] Garcia Garcia C, Casanovas N, Recasens L, Miranda F, Bruguera J. Spontaneous coronary artery dissection in ergotamine abuse. Int J Cardiol 2007;118:410–1. [2] Shimony A, Romem A, Horowitz S, Boehm R, Horowitz J. Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine. Int J Cardiol 2006;113:e7–8. [3] Schiff PL. Ergot and its alkaloids. Am J Pharm Educ 2006;70:98. [4] Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment ofmigraine: a review andEuropean consensus. Brain 2000;123: 9–18. [5] Molkara AM, Abou-Zamzam Jr AM, Teruya TH, Bianchi C, Killeen JD. Chronic ergot toxicity presenting with bilateral external iliac artery dissection and lower extremity rest pain. Ann Vasc Surg 2006;20: 803–8. [6] De Costa C. St Anthony's fire and living ligatures: a short history of ergometrine. Lancet 2002;359:1768–70. [7] Demeke T, Kidane Y, Wuhib E. Ergotism—a report on an epidemic, 1977–78. Ethiop Med J 1979;17:107–13. [8] Voyvodic F, Hayward M. Case report: upper extremity ischaemia secondary to ergotamine poisoning. Clin Radiol 1996;51:589–91. [9] Setola V, Hufeisen SJ, Grande-Allen KJ, et al. 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 2003;63:1223–9. [10] Baldwin ZK, Ceraldi CC. Ergotism associated with HIV antiviral protease inhibitor therapy. J Vasc Surg 2003;37:676–8. [11] Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003;48:133–43. [12] Zhou SF, Zhou ZW, Li CG, et al. Identification of drugs that interact with herbs in drug development. Drug Discov Today 2007;12:664–73. [13] EisenbergDM,KesslerRC, FosterC,NorlockFE,CalkinsDR,Delbanco TL. Unconventional medicine in theUnited States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246–52. [14] Shapiro LE, Shear NH. Drug interactions: proteins, pumps, and P-450s. J Am Acad Dermatol 2002;47:467–84. [15] Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131: 149–50.